Hungarian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glucosidase/elhízás

A hivatkozás a vágólapra kerül
15 eredmények

.alpha.-glucosidase inhibitors

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This invention relates to novel 1,4-di-deoxy-1,4-imino-D-arabinitol derivatives, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes. More specifically this invention relates to novel N-glycosyl derivatives of

.alpha.-glucosidase inhibitors from lichens

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND Glucosidase enzymes are involved in several biological processes such as the intestinal digestion, the biosynthesis of glycoproteins and the lysosomal catabolism of the glycoconjugates (Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of

Anti-obesity agent comprising compound containing benzotropolone ring

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
CROSS REFERENCE TO RELATED APPLICATIONS: This application is the National Stage of International Application No. PCT/JP2010/058624, filed May 21, 2010, and claims benefit of Japanese Application No. 2009-123585 filed May 21, 2009, which are herein incorporated by reference in their

Anti-obesity agent comprising compound containing benzotropolone ring

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
TECHNICAL FIELD The present invention relates to an anti-obesity agent containing a benzotropolone ring-containing compound. BACKGROUND ART Obesity is one of the most significant diseases in modern society and the main factor of obesity is excessive intake of fat. Excessive intake of fat is known to

Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
TECHNICAL FIELD The present invention relates to methods for inhibiting of alpha-glucosidases in subjects. In particular, the invention relates to the use of human pancreatic alpha-amylase inhibitors to reduce starch hydrolysis in subjects and further relates to the treatment of conditions
OBJECTS OF THE INVENTION It is an object of the invention to control weight in humans by ingesting acarbose with meals with food containing carbohydrates. This and other objects and advantages will become obvious from the following detailed description. THE INVENTION The invention is directed to a

Isomaltooligosaccharides from Leuconostoc as neutraceuticals

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as

Isomaltooligosaccharides to inhibit avian pathogenic intestinal bacteria

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as

Inosose derivatives, production and use thereof

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This invention relates to a novel inosose compound represented by the general formula: ##STR3## wherein X.sup.1 and X.sup.2 are both halogen, X.sup.1 is hydrogen and X.sup.2 is halogen, or X.sup.1 is --SQ.sup.1 and X.sup.2 is --SQ.sup.2 (each of Q.sup.1 and Q.sup.2 is lower alkyl or Q.sup.1 and

Inosose derivatives, production and use thereof

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
This invention relates to a novel inosose compound represented by the general formula: ##STR3## wherein X.sup.1 and X.sup.2 are both halogen, X.sup.1 is hydrogen and X.sup.2 is halogen, or X.sup.1 is --SQ.sup.1 and X.sup.2 is --SQ.sup.2 (each of Q.sup.1 and Q.sup.2 is lower alkyl or Q.sup.1 and

Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND TO THE INVENTION The present invention provides two novel polyhydroxycyclopentane derivatives which have certain valuable biological activities and provides methods of preparing these compounds as well as methods and compositions using them for therapeutic and prophylactic purposes. The

Methods of use and nutritional compositions of Touchi Extract

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
TECHNICAL FIELD The present invention relates generally to nutrition and more particularly to a method of use and nutritional compositions containing .alpha.-glucosidase inhibitors, and more specifically Touchi Extract. BACKGROUND OF THE INVENTION Touchi Extract (TE) is a water-extract powder of

Combination therapeutic compositions

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to

Combination therapeutic compositions and method of use

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to

Combination therapeutic compositions and method of use

Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to
Csatlakozzon
facebook oldalunkhoz

A legteljesebb gyógynövény-adatbázis, amelyet a tudomány támogat

  • Működik 55 nyelven
  • A tudomány által támogatott gyógynövényes kúrák
  • Gyógynövények felismerése kép alapján
  • Interaktív GPS térkép - jelölje meg a gyógynövényeket a helyszínen (hamarosan)
  • Olvassa el a keresésével kapcsolatos tudományos publikációkat
  • Keresse meg a gyógynövényeket hatásuk szerint
  • Szervezze meg érdeklődését, és naprakész legyen a hírkutatással, a klinikai vizsgálatokkal és a szabadalmakkal

Írjon be egy tünetet vagy betegséget, és olvassa el azokat a gyógynövényeket, amelyek segíthetnek, beírhat egy gyógynövényt, és megtekintheti azokat a betegségeket és tüneteket, amelyek ellen használják.
* Minden információ publikált tudományos kutatáson alapul

Google Play badgeApp Store badge